Data protection upheld for subsequently approved combination drugs containing new chemical entities: Federal Court finds Minister of Health’s decision to deny generic ANDS filing is reasonable August 6, 2020
Federal Court finds Minister’s CSP decision unreasonable on patent eligibility for fixed-dose combination drug product July 28, 2020
PMPRB update: Amendments delayed, new Guidelines consultation announced, and judicial review heard June 4, 2020
Federal Court issues first decision on patent term restoration – Minister’s decision denying certificate of supplementary protection (CSP) is unreasonable April 8, 2020
Ontario introduces formulary changes for generic drugs to mitigate risk of drug shortages March 31, 2020
